BioInvent International AB
STO:BINV
BioInvent International AB
EPS (Diluted)
BioInvent International AB
EPS (Diluted) Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | EPS (Diluted) | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
B
|
BioInvent International AB
STO:BINV
|
EPS (Diluted)
-kr6
|
CAGR 3-Years
-8%
|
CAGR 5-Years
3%
|
CAGR 10-Years
-33%
|
|
|
Biogaia AB
STO:BIOG B
|
EPS (Diluted)
kr3
|
CAGR 3-Years
22%
|
CAGR 5-Years
10%
|
CAGR 10-Years
N/A
|
|
|
Bonesupport Holding AB
STO:BONEX
|
EPS (Diluted)
kr1
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Vitrolife AB
STO:VITR
|
EPS (Diluted)
kr3
|
CAGR 3-Years
18%
|
CAGR 5-Years
1%
|
CAGR 10-Years
13%
|
|
|
Swedish Orphan Biovitrum AB (publ)
STO:SOBI
|
EPS (Diluted)
kr11
|
CAGR 3-Years
9%
|
CAGR 5-Years
0%
|
CAGR 10-Years
N/A
|
|
|
BioArctic AB
STO:BIOA B
|
EPS (Diluted)
-kr2
|
CAGR 3-Years
-14%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
BioInvent International AB
Glance View
BioInvent International AB engages in the research and development of novel and immuno-modulatory antibodies for the treatment of cancer. The company is headquartered in Lund, Skane and currently employs 84 full-time employees. The company went IPO on 2001-06-12. The Company’s operational activities are focused on expanding the clinical development of human antibodies, such as BI-1206, BI-1808, BI-1607 and BT-001. The firm has one wholly-owned subsidiary BioInvent Finans AB, which engaged in the administration of warrants issued by the Company.
See Also
What is BioInvent International AB's EPS (Diluted)?
EPS (Diluted)
-6.5
SEK
Based on the financial report for Dec 31, 2024, BioInvent International AB's EPS (Diluted) amounts to -6.5 SEK.
What is BioInvent International AB's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 10Y
-33%
Over the last year, the EPS (Diluted) growth was -30%. The average annual EPS (Diluted) growth rates for BioInvent International AB have been -8% over the past three years , 3% over the past five years , and -33% over the past ten years .
You don't have any saved screeners yet